# Starbucks Corp: financial statements, quarterly

SBUX · Nasdaq · CIK 829224 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Sep 28

Pages: [Overview](/companies/sbux.md) · [Financials](/companies/sbux/financials.md) · [Filings](/companies/sbux/filings.md) · [Insiders](/companies/sbux/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sbux/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-01) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9,374 d](/filings/0000829224-25-000114.md) | [9,425](/filings/0000829224-25-000014.md) | [8,563](/filings/0000829224-25-000034.md) | [9,114](/filings/0000829224-25-000058.md) | [9,074 d](/filings/0000829224-25-000114.md) | [9,398](/filings/0000829224-26-000011.md) | [8,762](/filings/0000829224-26-000080.md) | [9,456](/filings/0000829224-26-000130.md) | [9,569 d](/filings/0000829224-25-000114.md) | [9,915](/filings/0000829224-26-000011.md) | [9,532](/filings/0000829224-26-000080.md) | [9,323](/filings/0000829224-26-000130.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [1,706 d](/filings/0000829224-25-000114.md) | [1,485](/filings/0000829224-25-000014.md) | [1,099](/filings/0000829224-25-000034.md) | [1,518](/filings/0000829224-25-000058.md) | [1,307 d](/filings/0000829224-25-000114.md) | [1,122](/filings/0000829224-26-000011.md) | [601](/filings/0000829224-26-000080.md) | [936](/filings/0000829224-26-000130.md) | [278 d](/filings/0000829224-25-000114.md) | [891](/filings/0000829224-26-000011.md) | [828](/filings/0000829224-26-000080.md) | [980](/filings/0000829224-26-000130.md) |
| Interest expense | $m | [143 d](/filings/0000829224-25-000114.md) | [140](/filings/0000829224-25-000014.md) | [141](/filings/0000829224-25-000034.md) | [141](/filings/0000829224-25-000058.md) | [140 d](/filings/0000829224-25-000114.md) | [127](/filings/0000829224-26-000011.md) | [127](/filings/0000829224-26-000080.md) | [142](/filings/0000829224-26-000130.md) | [146 d](/filings/0000829224-25-000114.md) | [139](/filings/0000829224-26-000011.md) | [137](/filings/0000829224-26-000080.md) | [135](/filings/0000829224-26-000130.md) |
| Income tax | $m | [374 d](/filings/0000829224-25-000114.md) | [355](/filings/0000829224-25-000014.md) | [220](/filings/0000829224-25-000034.md) | [349](/filings/0000829224-25-000058.md) | [284 d](/filings/0000829224-25-000114.md) | [241](/filings/0000829224-26-000011.md) | [118](/filings/0000829224-26-000080.md) | [260](/filings/0000829224-26-000130.md) | [30.7 d](/filings/0000829224-25-000114.md) | [472](/filings/0000829224-26-000011.md) | [217](/filings/0000829224-26-000080.md) | [374](/filings/0000829224-26-000130.md) |
| Net income | $m | [1,219 d](/filings/0000829224-25-000114.md) | [1,024](/filings/0000829224-25-000014.md) | [772](/filings/0000829224-25-000034.md) | [1,055](/filings/0000829224-25-000058.md) | [909 d](/filings/0000829224-25-000114.md) | [781](/filings/0000829224-26-000011.md) | [384](/filings/0000829224-26-000080.md) | [558](/filings/0000829224-26-000130.md) | [133 d](/filings/0000829224-25-000114.md) | [293](/filings/0000829224-26-000011.md) | [511](/filings/0000829224-26-000080.md) | [1,045](/filings/0000829224-26-000130.md) |
| Diluted EPS | $ per share | not reported | [0.90](/filings/0000829224-25-000014.md) | [0.68](/filings/0000829224-25-000034.md) | [0.93](/filings/0000829224-25-000058.md) | not reported | [0.69](/filings/0000829224-26-000011.md) | [0.34](/filings/0000829224-26-000080.md) | [0.49](/filings/0000829224-26-000130.md) | not reported | [0.26](/filings/0000829224-26-000011.md) | [0.45](/filings/0000829224-26-000080.md) | [0.91](/filings/0000829224-26-000130.md) |
| Basic EPS | $ per share | not reported | [0.90](/filings/0000829224-25-000014.md) | [0.68](/filings/0000829224-25-000034.md) | [0.93](/filings/0000829224-25-000058.md) | not reported | [0.69](/filings/0000829224-26-000011.md) | [0.34](/filings/0000829224-26-000080.md) | [0.49](/filings/0000829224-26-000130.md) | not reported | [0.26](/filings/0000829224-26-000011.md) | [0.45](/filings/0000829224-26-000080.md) | [0.92](/filings/0000829224-26-000130.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-01) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [7.3](/filings/0000829224-24-000057.md) | [6.6](/filings/0000829224-24-000013.md) | [6.5](/filings/0000829224-24-000024.md) | [6.8](/filings/0000829224-24-000042.md) | [6.8](/filings/0000829224-25-000114.md) | [7.3](/filings/0000829224-25-000014.md) | [6.7](/filings/0000829224-25-000034.md) | [8.4](/filings/0000829224-25-000058.md) | [7.4](/filings/0000829224-26-000130.md) | [12.0](/filings/0000829224-26-000011.md) | [10.6](/filings/0000829224-26-000080.md) | [7.5](/filings/0000829224-26-000130.md) |
| Total assets | $bn | [29.4](/filings/0000829224-24-000057.md) | [29.2](/filings/0000829224-24-000013.md) | [29.4](/filings/0000829224-24-000024.md) | [30.1](/filings/0000829224-24-000042.md) | [31.3](/filings/0000829224-25-000114.md) | [31.9](/filings/0000829224-25-000014.md) | [31.6](/filings/0000829224-25-000034.md) | [33.6](/filings/0000829224-25-000058.md) | [32.0](/filings/0000829224-26-000130.md) | [32.2](/filings/0000829224-26-000011.md) | [30.6](/filings/0000829224-26-000080.md) | [28.3](/filings/0000829224-26-000130.md) |
| Current liabilities | $bn | [9.3](/filings/0000829224-24-000057.md) | [9.4](/filings/0000829224-24-000013.md) | [7.5](/filings/0000829224-24-000024.md) | [7.6](/filings/0000829224-24-000042.md) | [9.1](/filings/0000829224-25-000114.md) | [9.7](/filings/0000829224-25-000014.md) | [10.4](/filings/0000829224-25-000034.md) | [11.1](/filings/0000829224-25-000058.md) | [10.2](/filings/0000829224-26-000130.md) | [11.5](/filings/0000829224-26-000011.md) | [11.4](/filings/0000829224-26-000080.md) | [9.9](/filings/0000829224-26-000130.md) |
| Total liabilities | $bn | [37.4](/filings/0000829224-24-000057.md) | [37.8](/filings/0000829224-24-000013.md) | [37.8](/filings/0000829224-24-000024.md) | [38.0](/filings/0000829224-24-000042.md) | [38.8](/filings/0000829224-25-000114.md) | [39.4](/filings/0000829224-25-000014.md) | [39.2](/filings/0000829224-25-000034.md) | [41.3](/filings/0000829224-25-000058.md) | [40.1](/filings/0000829224-26-000130.md) | [40.6](/filings/0000829224-26-000011.md) | [39.0](/filings/0000829224-26-000080.md) | [36.0](/filings/0000829224-26-000130.md) |
| Long-term debt | $bn | [13.5](/filings/0000829224-24-000057.md) | [13.6](/filings/0000829224-24-000013.md) | [15.5](/filings/0000829224-24-000024.md) | [15.6](/filings/0000829224-24-000042.md) | [14.3](/filings/0000829224-25-000114.md) | [14.3](/filings/0000829224-25-000014.md) | [13.3](/filings/0000829224-25-000034.md) | [14.6](/filings/0000829224-25-000058.md) | [14.6](/filings/0000829224-26-000130.md) | [14.6](/filings/0000829224-26-000011.md) | [13.1](/filings/0000829224-26-000080.md) | [11.8](/filings/0000829224-26-000130.md) |
| Current portion of debt | $bn | [1.8](/filings/0000829224-24-000057.md) | [1.1](/filings/0000829224-24-000013.md) | [0.0](/filings/0000829224-24-000024.md) | [0.0](/filings/0000829224-24-000042.md) | [1.2](/filings/0000829224-25-000114.md) | [1.2](/filings/0000829224-25-000014.md) | [2.2](/filings/0000829224-25-000034.md) | [2.7](/filings/0000829224-25-000058.md) | [1.5](/filings/0000829224-26-000130.md) | [1.5](/filings/0000829224-26-000011.md) | [2.0](/filings/0000829224-26-000080.md) | [1.5](/filings/0000829224-26-000130.md) |
| Short-term borrowings | $bn | [0.0](/filings/0000829224-24-000057.md) | [0.3](/filings/0000829224-24-000013.md) | [0.0](/filings/0000829224-24-000024.md) | [0.0](/filings/0000829224-24-000042.md) | [0.0](/filings/0000829224-24-000057.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [(8.0)](/filings/0000829224-24-000057.md) | [(8.6)](/filings/0000829224-24-000013.md) | [(8.4)](/filings/0000829224-24-000024.md) | [(7.9)](/filings/0000829224-24-000042.md) | [(7.4)](/filings/0000829224-25-000114.md) | [(7.5)](/filings/0000829224-25-000014.md) | [(7.6)](/filings/0000829224-25-000034.md) | [(7.7)](/filings/0000829224-25-000058.md) | [(8.1)](/filings/0000829224-26-000130.md) | [(8.4)](/filings/0000829224-26-000011.md) | [(8.5)](/filings/0000829224-26-000080.md) | [(7.7)](/filings/0000829224-26-000130.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-01) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,945 d](/filings/0000829224-25-000114.md) | [2,384](/filings/0000829224-25-000014.md) | [506 d](/filings/0000829224-25-000034.md) | [1,670 d](/filings/0000829224-25-000058.md) | [1,536 d](/filings/0000829224-25-000114.md) | [2,072](/filings/0000829224-26-000011.md) | [292 d](/filings/0000829224-26-000080.md) | [1,002 d](/filings/0000829224-26-000130.md) | [1,382 d](/filings/0000829224-25-000114.md) | [1,598](/filings/0000829224-26-000011.md) | [365 d](/filings/0000829224-26-000080.md) | [1,642 d](/filings/0000829224-26-000130.md) |
| Capital expenditure | $m | [700 d](/filings/0000829224-25-000114.md) | [596](/filings/0000829224-25-000014.md) | [659 d](/filings/0000829224-25-000034.md) | [724 d](/filings/0000829224-25-000058.md) | [798 d](/filings/0000829224-25-000114.md) | [693](/filings/0000829224-26-000011.md) | [589 d](/filings/0000829224-26-000080.md) | [567 d](/filings/0000829224-26-000130.md) | [456 d](/filings/0000829224-25-000114.md) | [324](/filings/0000829224-26-000011.md) | [273 d](/filings/0000829224-26-000080.md) | [291 d](/filings/0000829224-26-000130.md) |
| Dividends paid | $m | [607 d](/filings/0000829224-25-000114.md) | [648](/filings/0000829224-25-000014.md) | [645 d](/filings/0000829224-25-000034.md) | [646 d](/filings/0000829224-25-000058.md) | [646 d](/filings/0000829224-25-000114.md) | [692](/filings/0000829224-26-000011.md) | [693 d](/filings/0000829224-26-000080.md) | [693 d](/filings/0000829224-26-000130.md) | [693 d](/filings/0000829224-25-000114.md) | [705](/filings/0000829224-26-000011.md) | [706 d](/filings/0000829224-26-000080.md) | [707 d](/filings/0000829224-26-000130.md) |
| Share repurchases | $m | [285 d](/filings/0000829224-25-000114.md) | [1,267](/filings/0000829224-25-000014.md) | [0.0 d](/filings/0000829224-25-000034.md) | [0.0 d](/filings/0000829224-25-000058.md) | [0.0 d](/filings/0000829224-25-000114.md) | [0.0](/filings/0000829224-25-000014.md) | [0.0 d](/filings/0000829224-25-000034.md) | [0.0 d](/filings/0000829224-25-000058.md) | [0.0 d](/filings/0000829224-25-000114.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-01) | Q2 FY2023 (2023-04-02) | Q3 FY2023 (2023-07-02) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,153](/filings/0000829224-24-000013.md) | [1,153](/filings/0000829224-24-000024.md) | [1,151](/filings/0000829224-24-000042.md) | [1,141](/filings/0000829224-25-000014.md) | [1,135](/filings/0000829224-25-000034.md) | [1,136](/filings/0000829224-25-000058.md) | [1,138](/filings/0000829224-26-000011.md) | [1,140](/filings/0000829224-26-000080.md) | [1,140](/filings/0000829224-26-000130.md) | [1,142](/filings/0000829224-26-000011.md) | [1,143](/filings/0000829224-26-000080.md) | [1,144](/filings/0000829224-26-000130.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,140,000,000 at 2026-07-23, from the cover of the [10-Q filed 2026-07-29](/filings/0000829224-26-000130.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.